Who owns ONKURE THERAPEUTICS INC-A?
- Ticker: OKUR
- CUSIP Number: 68277q105
Tip: Access positions for across all investors
Analyze quarterly positions in Onkure Therapeutics Inc-a with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Onkure Therapeutics Inc-a stock
Who bought or sold ONKURE THERAPEUTICS INC-A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.0M | $17M | 100% | Mar 2026 |
|
| Acorn Capital Advisors | 2.8M | $8.2M | 0% | Dec 2025 |
|
| StepStone | 2.7M | $11M | 441% | Mar 2026 |
|
| ADAR1 Capital Management | 2.4M | $10M | 140% | Mar 2026 |
|
| BVF | 2.0M | $8.2M | 100% | Mar 2026 |
|
| Vivo Capital | 1.9M | $8.0M | 100% | Mar 2026 |
|
| Vestal Point Capital | 1.8M | $7.6M | 190% | Mar 2026 |
|
| Foresite Capital Management VI | 1.4M | $6.0M | 100% | Mar 2026 |
|
| Prosight Management | 817k | $2.4M | 205% | Dec 2025 |
|
| Rosalind Advisors | 731k | $2.1M | 100% | Dec 2025 |
|
| Vanguard Group | 627k | $1.8M | -8% | Dec 2025 |
|
| Vanguard Capital Management | 583k | $2.4M | 100% | Mar 2026 |
|
| Highbridge Capital Management | 542k | $1.6M | -17% | Dec 2025 |
|
| NEA Management Company | 479k | $2.0M | 0% | Mar 2026 |
|
| Carlyle | 270k | $1.1M | 0% | Mar 2026 |
|
| Renaissance Technologies | 247k | $717k | 41% | Dec 2025 |
|
| DV Trading | 241k | $998k | 100% | Mar 2026 |
|
| Sofinnova Ventures | 142k | $587k | 100% | Mar 2026 |
|
| Shay Capital | 132k | $547k | 100% | Mar 2026 |
|
| Cantor Fitzgerald, L. P. | 100k | $414k | -78% | Mar 2026 |
|
| Geode Capital Management | 99k | $409k | 27% | Mar 2026 |
|
| Rangeley Capital | 95k | $393k | -34% | Mar 2026 |
|
| Aisling Capital Management | 89k | $367k | 0% | Mar 2026 |
|
| BlackRock | 50k | $205k | -6% | Mar 2026 |
|
| Goss Wealth Management | 45k | $184k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 43k | $180k | 100% | Mar 2026 |
|
| Aldebaran Capital | 40k | $167k | -2% | Mar 2026 |
|
| Citadel Advisors | 38k | $156k | -83% | Mar 2026 |
|
| Hrt Financial | 37k | $153k | 100% | Mar 2026 |
|
| Millennium Management | 31k | $126k | 100% | Mar 2026 |
|
| Barclays | 27k | $79k | 4287% | Dec 2025 |
|
| Jane Street | 27k | $111k | 38% | Mar 2026 |
|
| Two Sigma Investments | 24k | $100k | 114% | Mar 2026 |
|
| GSA Capital Partners | 22k | $92k | -52% | Mar 2026 |
|
| Northern Trust | 20k | $58k | -12% | Dec 2025 |
|
| Bridgeway Capital Management | 20k | $57k | 0% | Dec 2025 |
|
| XTX Topco | 18k | $52k | 100% | Dec 2025 |
|
| Morgan Stanley | 14k | $59k | -43% | Mar 2026 |
|
| Wells Fargo & Company | 14k | $56k | 23% | Mar 2026 |
|
| UBS Group | 3.4k | $14k | 181% | Mar 2026 |
|
| Vanguard Global Advisers | 745.00 | $3.1k | 100% | Mar 2026 |
|
| FMR | 400.00 | $1.2k | 700% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 281.00 | $1.2k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 230.00 | $999.994000 | 21% | Mar 2026 |
|
| Trust Co Of Toledo Na | 136.00 | $562.999200 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 109.00 | $316.001900 | 9% | Dec 2025 |
|
| Citigroup | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Onkure Therapeutics Inc-a?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| None | Dec 2025 | 781k | $2.3M |
| Sphera Funds Management | Dec 2025 | 61k | $175k |
| Two Sigma Advisers | Dec 2025 | 27k | $77k |
| Hsbc Holdings | Dec 2025 | 20k | $58k |
| Tower Research Capital | Sep 2025 | 1.9k | $5.3k |
| Jpmorgan Chase & Co | Sep 2025 | 423.00 | $1.2k |
| Group One Trading | Dec 2025 | 56.00 | $162.002400 |
| Northwestern Mutual Wealth Management Company | Dec 2025 | 2.00 | $6.000000 |